Enveric Biosciences, Inc.
ENVB · NASDAQ
Bulios Fair Price
$1.72
17.8% upside
Current Price
$1.46
According to Bulios Fair Price, ENVB is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Enveric Biosciences Inc. (ENVB) is a biopharmaceutical company focused on developing innovative therapeutic products for the treatment of symptoms associated with cancer and other chronic diseases. The company specializes in the research and development of cannabinoid-based therapies and other natural compounds that offer patients hope for relief from pain, inflammation, and other challenges associated with illness.
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph Edward Tucker
Employees
6
Headquarters
Cambridge
Upcoming events
Earnings
Upcoming earnings report